等待开盘 10-10 09:30:00 美东时间
0.000
0.00%
MY RUFF DAY series spotlights cutting edge technology SAN ANTONIO, May 20, 2024...
2024-05-20 18:03
First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published
2023-08-14 21:46
Clinical-stage psychedelics biotech Reunion Neuroscience (NASDAQ: REUN) and MPM BioImpact have completed their announced plan of arrangement for MPM&rsq
2023-08-02 03:43
As Reunion Neuroscience (NASDAQ: REUN) and Mindset Pharma (OTCMKTS: MSSTF) continue their court battle over claims on a novel 4-OH-DiPT prodrug, private biotech company Terran Biosciences has also filed a patent application over a proprietary polymorph,
2023-07-19 08:47
Reunion Neuroscience (NASDAQ:REUN) reported its Q4 earnings results on Thursday...
2023-06-29 20:25
https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs
2023-06-23 22:33
NEW YORK, June 13, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2023-06-14 09:50
Reunion Neuroscience Inc.(NASDAQ:REUN) shares are trading lower on Friday...
2023-06-02 22:26
U.S. stocks extended gains toward the end of trading, with Nasdaq gaining more than 1% on Thursday. The Dow traded up 0.66% to 33,125.22 while the NASDAQ rose 1.2% to 13,090.62. The S&P 500, also rose, gaining, 0.97% to 4,220.42.
2023-06-02 02:42
U.S. stocks turned higher midway through trading, with Nasdaq gaining around 100 points on Thursday. The Dow traded up 0.27% to 32,996.06 while the NASDAQ rose 0.76% to 13,034.08. The S&P 500, also rose, gaining, 0.59% to 4,204.69.
2023-06-02 00:05